Skip to main content
Mark Atkinson, MD, Anesthesiology, Kalamazoo, MI

MarkBAtkinsonMD

Anesthesiology • Kalamazoo, MI

Anesthesiologist

Join to view full profile

Dr. Atkinson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Atkinson's full profile

Already have an account?

  • Office

    900 Peeler St
    Kalamazoo, MI 49008
    Phone+1 726-221-8833
    Fax+1 269-345-1508

Summary

  • Mark Atkinson, MD, is a board-certified anesthesiologist with Kalamazoo Anesthesiology in Kalamazoo, Michigan. He is a graduate of Eastern Illinois University in Charleston, Illinois. He earned his medical degree from University of Illinois at Chicago College of Medicine in Chicago, Illinois. He completed his anesthesiology residency with Medical College of Ohio in Cincinnati, Ohio.

Education & Training

  • University of Toledo
    University of ToledoResidency, Anesthesiology, 1985 - 1987
  • University of Toledo
    University of ToledoInternship, Transitional Year, 1984 - 1985
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1984

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1987 - 2027
  • OH State Medical License
    OH State Medical License 1985 - 1988
  • American Board of Anesthesiology Anesthesiology

Publications & Presentations

PubMed

Lectures

  • Granulocyte Colony Stimulating Factor (GCSF) Fails to Preserve Beta-Cell Function in Patients with Recent Onset Type 1 Diabetes (T1D) 
    Gainesville, FL - 6/15/2014
  • IL-12 and IL-18 Potentiate Th1-immunity and Cytotoxic T Cell-mediated Killing of Human ßLox5 Cells 
    Gainesville, FL - 6/15/2014

Press Mentions

  • FDA Advisory Committee Recommends Approval of Immunotherapy to Delay Type 1 Diabetes
    FDA Advisory Committee Recommends Approval of Immunotherapy to Delay Type 1 DiabetesMay 27th, 2021
  • Researchers Look at Possible Coronavirus-Diabetes Link
    Researchers Look at Possible Coronavirus-Diabetes LinkSeptember 6th, 2020
  • Headteachers Beg Parents to Reconsider if They’re a ‘Key Worker’ as Some Threaten to SUE Schools
    Headteachers Beg Parents to Reconsider if They’re a ‘Key Worker’ as Some Threaten to SUE SchoolsMarch 30th, 2020
  • Join now to see all

Dr. Mark Atkinson, Dr. Mark Atkinson, MD, Dr. M Atkinson, Dr. Mark B Atkinson